Skip to main content
. Author manuscript; available in PMC: 2013 Sep 16.
Published in final edited form as: Shock. 2010 Sep;34(3):281–290. doi: 10.1097/SHK.0b013e3181cdc327

Table 2.

Hemodynamic measurements 22h after CASP or sham operation

WT NOS3KO
n sham
5
CASP
8
sham
6
CASP
7
HR, bpm 567±11 567±11 538±13 547±21
LVESP, mmHg 111±4 77±6 131±6# 84±10*
LVEDP, mmHg 2±0 5±1 3±0 8±2*#
dP/dtmax, mmHg/s 19768±1084 11667±1726* 17637±369 6527±795*#
dP/dtmin, mmHg/s −9974±875 −9809±1071 −11363±1505 −5013±728*#
EF, % 61±4 45±3* 69±4 34±4*#
CO, ml/min 14.8±1.6 17.5±1.8 13.5±2.1 8.1±1.3*#
dP/dtmax/IP, s−1 222±8 219±8 201±15 135±21*#
Ea, mmHg/μL 3±2 3±1 5±1 6±1#
Ees, mmHg/μL 27±6 16±3 30±6 10±1*
Ea/Ees 0.1±0.1 0.2±0.1 0.2±0.1 0.6±0.1*#
τ, msec 5.5±0.2 4.6±0.2 5.5±0.1 8.5±1.2*#

Values are means ± SE. HR, heart rate; LVESP, left ventricular end-systolic pressure; LVEDP, left ventricular end-diastolic pressure; dP/dtmax, maximum rate of developed left ventricular pressure; dP/dtmin, minimum rate of developed left ventricular pressure; EF, ejection fraction; CO, cardiac output; dP/dtmax/IP, dP/dtmax divided by instantaneous pressure; Ea, arterial elastance; Ees, left ventricular end-systolic elastance; Ea/Ees, ratio of Ea to Ees; τ, time constant of isovolumic relaxation.

*

P<0.05 vs sham-operated mice of the same genotype.

#

P<0.05 vs WT mice with the same operation.

HHS Vulnerability Disclosure